Literature DB >> 12196718

Analysis of gene expression involved in brain metastasis from breast cancer using cDNA microarray.

Itaru Nishizuka1, Takashi Ishikawa, Yohei Hamaguchi, Masako Kamiyama, Yasushi Ichikawa, Koji Kadota, Rika Miki, Yasuhiro Tomaru, Yosuke Mizuno, Naoko Tominaga, Rieko Yano, Hitoshi Goto, Hiroyuki Nitanda, Shinji Togo, Y Okazaki, Yoshihide Hayashizaki, Hiroshi Shimada.   

Abstract

BACKGROUND: Brain metastases occur in 15% to 30% of breast cancer patients, usually as a late event. The patterns of metastases to different organs are determined by the tumor cell phenotype and interactions between the tumor cells and the organ environment.
METHODS: We investigated the gene expression profile occurring in brain metastases from a breast cancer cell line. We used cDNA microarrays to compare patterns of gene expression between the mouse breast cancer cell line Jyg MC (A) and a subline that often metastasis to brain, (B).
RESULTS: By Microarray analysis about 350 of 21,000 genes were significantly up-regulated in Jyg MC (B). Many candidate genes that may be associated with the establishment of brain metastasis from breast cancer were included. Interestingly, we found that the expression of astrocyte derived cytokine receptors (IL-6 receptor, TGF-beta receptor and IGF receptor) were significantly increased in Jyg MC (B) cells. These results were confirmed by RT-PCR.
CONCLUSIONS: These results suggest that cytokines produced by glial cells in vivo may contribute, in a paracrine manner, to the development of brain metastases from breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196718     DOI: 10.1007/bf02967543

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  15 in total

1.  Mining microarrays for metabolic meaning: nutritional regulation of hypothalamic gene expression.

Authors:  Charles V Mobbs; Kelvin Yen; Jason Mastaitis; Ha Nguyen; Elizabeth Watson; Elisa Wurmbach; Stuart C Sealfon; Andrew Brooks; Stephen R J Salton
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.

Authors:  Xiaojia Chen; Jia Lu; Yuhua Ji; An Hong; Qiuling Xie
Journal:  Tumour Biol       Date:  2013-09-12

3.  Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors:  Odete Mendes; Hun-Taek Kim; George Stoica
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Glycomic profiling of invasive and non-invasive breast cancer cells.

Authors:  John A Goetz; Yehia Mechref; Pilsoo Kang; Meei-Huey Jeng; Milos V Novotny
Journal:  Glycoconj J       Date:  2008-08-28       Impact factor: 2.916

5.  Clinical significance of KISS1 protein expression for brain invasion and metastasis.

Authors:  Ilya V Ulasov; Natalya V Kaverina; Peter Pytel; Bart Thaci; Feifei Liu; Douglas R Hurst; Danny R Welch; Husein A Sattar; Olufunmilayo I Olopade; Anatoly Y Baryshnikov; Zaira G Kadagidze; Maciej S Lesniak
Journal:  Cancer       Date:  2011-09-16       Impact factor: 6.860

Review 6.  Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network.

Authors:  Bahrami Tayyeb; Mehdipour Parvin
Journal:  Mol Neurobiol       Date:  2014-12-04       Impact factor: 5.590

Review 7.  Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.

Authors:  Colleen S Curran; Patricia J Keely
Journal:  Matrix Biol       Date:  2012-12-20       Impact factor: 11.583

8.  Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization.

Authors:  Daniel P Fitzgerald; Diane Palmieri; Emily Hua; Elizabeth Hargrave; Jeanne M Herring; Yongzhen Qian; Eleazar Vega-Valle; Robert J Weil; Andreas M Stark; Alexander O Vortmeyer; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2008-07-23       Impact factor: 5.150

9.  MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2.

Authors:  Odete Mendes; Hun-Taek Kim; Gina Lungu; George Stoica
Journal:  Clin Exp Metastasis       Date:  2007-05-16       Impact factor: 5.150

10.  High frequency of complex TP53 mutations in CNS metastases from breast cancer.

Authors:  C Lo Nigro; D Vivenza; M Monteverde; L Lattanzio; O Gojis; O Garrone; A Comino; M Merlano; P R Quinlan; N Syed; C A Purdie; A Thompson; C Palmieri; T Crook
Journal:  Br J Cancer       Date:  2011-12-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.